ENTITY

Anebulo Pharmaceuticals (ANEB US)

2
Analysis
Health Care • United States
Anebulo Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing disruptive treatments for substance use disorders, such as cannabinoid overdose and the broader addiction landscape. Anebulo Pharmaceuticals serves customers in the United States.
more
•22 Oct 2025 22:53•Syndicated

Anebulo Pharma Inc (ANEB) - Wednesday, Jul 23, 2025

The author warns about Anebulo Pharmaceuticals' planned reverse stock split to reduce shareholders and avoid SEC costs, highlighting financial...

Share
bullish•Kraft Heinz Co
•28 Jul 2025 09:28

Weekly Update (AAF, NLOP, KHC)

Kraft Heinz (KHC) is currently evaluating a plan to spin off a significant portion of its grocery business into a new, distinct entity. The WSJ...

Logo
270 Views
Share
x